EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucose-Fueled Gold Nanozymes Achieve Picomolar Eradication of Drug-Resistant Staphylococcus aureus

Fatiha Farhana, Guanyu Chen, Rebecca L Stratton iD, Bishal Pokhrel, Adeola Adeyemi, Songping D Huang iD, Hao Shen iD

ACS Applied Bio Materials · 09.11.2026

DOI: 10.1021/acsabm.6c01114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 09.11.2026. Verfasst von Fatiha Farhana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Kent State University, Kent, Ohio44242, United States. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Chemistry, Kent State University's Farris Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) represents a worsening global health emergency, with projections estimating more than 39 million deaths attributable to drug-resistant bacteria by 2050. Diabetic patients face a compounded threat: chronic hyperglycemia suppresses host immunity while enriching wound microenvironments with glucose, accelerating methicillin-resistant Staphylococcus aureus (MRSA) proliferation and rendering conventional antibiotics increasingly ineffective. Here, we report a minimalist, enzyme-free antibacterial strategy based on citrate-stabilized 30 nm gold nanoparticles (AuNPs) that exploit this glucose surplus as a catalytic substrate. Through intrinsic glucose oxidase- and peroxidase-like dual activities, these AuNPs convert ambient glucose and oxygen into a localized cascade of bactericidal reactive oxygen species (ROS), achieving >90% growth inhibition against both methicillin-susceptible S. aureus (MSSA) and MRSA USA300 at concentrations as low as 12.5 pM. Scavenger experiments establish oxidative membrane damage as the primary killing mechanism, and SEM and TEM analyses confirm that AuNPs preferentially accumulate at the bacterial cell membrane, confining ROS production to the site of maximum biological vulnerability. This membrane-localized catalysis, further amplified by brief 532 nm irradiation, accounts for the marked superiority of spherical AuNPs over gold nanorods of comparable composition, demonstrating that spatial localization rather than bulk ROS output governs the killing efficiency. This glucose-fueled, antibiotic-free platform offers a rational strategy for treating drug-resistant infections in hyperglycemic wound environments.

Schlagwörter

Stichwörter der Autor:innen

MRSAantimicrobial resistanceglucose oxidationgold nanoparticlesmembrane-localized catalysisnanozymereactive oxygen species

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Kent State University, Kent, Ohio44242, United States.
  • Advanced Materials and Liquid Crystal Institute, Kent State University, Kent, Ohio44242, United States.

ORCID-Profile: Rebecca L Stratton, Songping D Huang, Hao Shen

Förderung

  • Division of Chemistry
  • Kent State University's Farris Family Foundation

Zitieren

APA

Farhana, F., Chen, G., Stratton, R. L., Pokhrel, B., Adeyemi, A., Huang, S. D., & Shen, H. (2026). Glucose-Fueled Gold Nanozymes Achieve Picomolar Eradication of Drug-Resistant Staphylococcus aureus. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01114

Vancouver

Farhana F, Chen G, Stratton RL, Pokhrel B, Adeyemi A, Huang SD, et al. Glucose-Fueled Gold Nanozymes Achieve Picomolar Eradication of Drug-Resistant Staphylococcus aureus. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01114

BibTeX
@article{Farhana2026,
  author = {Farhana, Fatiha and Chen, Guanyu and Stratton, Rebecca L and Pokhrel, Bishal and Adeyemi, Adeola and Huang, Songping D and Shen, Hao},
  title = {Glucose-Fueled Gold Nanozymes Achieve Picomolar Eradication of Drug-Resistant Staphylococcus aureus},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c01114}
}
Kostenlos starten →